香港股市 將在 6 小時 48 分鐘 開市

MRK Feb 2023 90.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.0500-0.0100 (-16.67%)
市場開市。 截至 01:01PM EST。
全螢幕
前收市價0.0600
開市0.0500
買盤0.0400
賣出價0.1000
拍板90.00
到期日2023-02-17
今日波幅0.0500 - 0.0500
合同範圍
成交量1
未平倉合約2.01k
  • Benzinga

    Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023

    Merck & Co Inc's (NYSE: MRK) Q4 sales reached $13.8 billion, +2% Y/Y, beating the consensus of $13.67 billion. Excluding the foreign exchange impact, revenues were up 8%. Pharmaceutical sales increased by 1% to $12.2 billion. Excluding the unfavorable impact of foreign exchange, pharmaceutical sales grew 9%, primarily driven by oncology and hospital acute care, partially offset by diabetes. Growth in oncology was primarily driven by higher sales of Keytruda, which rose 19% to $5.5 billion. Relat

  • Insider Monkey

    15 Undervalued Defensive Stocks For 2023

    In this article, we will take a look at the 15 undervalued defensive stocks for 2023. You can skip this part and go to 5 Undervalued Defensive Stocks For 2023. Investors flocked to defensive stocks in 2022 amid recession fears and massive losses in the growth stocks space. Defensive stocks are favored by investors during […]

  • Insider Monkey

    Is Merck & Co. (MRK) a Long-Term Bet?

    Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund increased by 9.08% (Institutional Shares) compared to an 11.54% gain for the Russell 3000 Health Care Index and a 7.56% gain for the S&P […]